Latest News & Features
Big Pharma
Six organisations have appealed against the European Patent Office’s decision to uphold a patent for a key hepatitis C drug. 10 December 2018
Big Pharma
The US Food and Drug Administration has announced a new strategy for the use of “real-world evidence” and “real-world data” to improve its regulation of new drugs. 7 December 2018
Big Pharma
The European Federation of Pharmaceutical Industries and Associations has sharply criticised an opinion on supplementary protection certificate proposals that was issued by a European Parliament committee. 6 December 2018
Americas
American conglomerate GE Healthcare last week filed a lawsuit against California-based life sciences company Bio-Rad Laboratories on four counts of patent infringement. 5 December 2018
Americas
US-based Allele Biotechnology & Pharmaceuticals, a preclinical-stage biopharmaceutical company, has teamed up with a scientific e-commerce marketplace network in efforts to develop nanoantibodies for therapeutic applications. 5 December 2018
Big Pharma
The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage. 5 December 2018
Americas
German pharmaceutical company Boehringer Ingelheim has signed a research collaboration and licence agreement with French and Canadian biopharmaceutical business Domain Therapeutics. 4 December 2018
Americas
GSK has agreed to buy US oncology company Tesaro for $5.1 billion, in a move designed to strengthen its anti-cancer offering. 3 December 2018
Americas
AbbVie has granted Pfizer a non-exclusive global licence to its Humira IP, as announced on Friday, November 30. 3 December 2018
Big Pharma
Proposed amendments to the EU’s supplementary protection certificate manufacturing waiver risk “further disincentivising investment” in Europe, according to the European Federation of Pharmaceutical Industries and Associations. 30 November 2018